Fund Holdings — GENERAL ATLANTIC, L.P.

Total Portfolio Value:
$3.18B
Total Bought:
$0
Total Sold:
$648.29M
Net Transaction:
-$648.29M
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
XP Inc.CL A(XP)29,617,73329,617,7330$759.99M$520.98M16.38%-$239.02M
DLocal LimitedCL A(DLO)63,906,69563,906,6950$939.43M$517.01M16.26%-$422.42M
Alkami Technology, Inc.(ALKT)18,729,80617,186,985-1,542,821$460.19M$489.49M15.39%+$29.29M
Alignment Healthcare, Inc.(ALHC)60,993,32360,993,3230$302.53M$476.97M15.00%+$174.44M
SquarespaceCL A10,611,07310,611,0730$386.67M$462.96M14.56%+$76.29M
Pharvaris
COM
7,531,2527,531,2520$174.05M$141.59M4.45%-$32.46M
European Wax CenterCL A
CLASS A COM
13,110,49213,110,4920$170.17M$130.19M4.09%-$39.99M
Akero Therapeutics5,233,9895,233,9890$132.21M$122.79M3.86%-$9.42M
Centessa PharmaceuticalsADS9,681,8189,681,8180$109.40M$87.43M2.75%-$21.98M
Blend Labs, Inc.CL A(BLND)19,132,44019,132,4400$62.18M$45.15M1.42%-$17.03M
Immunocore Holdings plcADS(IMCR)1,506,6841,261,684-245,000$97.93M$42.76M1.34%-$55.18M
Royalty Pharma plcCL A(RPRX)1,500,0001,500,0000$45.55M$39.55M1.24%-$6.00M
Third Harmonic Bio2,958,7622,958,7620$27.93M$38.46M1.21%+$10.53M
Riskified Ltd.CL A(RSKD)5,324,9985,324,9980$28.81M$34.03M1.07%+$5.22M
Acelyrin2,889,6682,889,6680$19.51M$12.74M0.40%-$6.76M
Opendoor Technologies Inc.(OPEN)6,321,5196,321,5190$19.15M$11.63M0.37%-$7.52M
WishCL A609,616609,6160$3.47M$3.48M0.11%+$12.2K
Grove Collaborative Holdings, Inc.CL A(GROV)936,020936,0200$1.56M$1.66M0.05%+$93.6K
AdageneADS264,000264,0000$739.2K$807.8K0.03%+$68.6K
Hireright32,109,8980-32,109,898$458.21M$0—-$458.21M
HUTCHMED (China) LimitedADS(HCM)4,000,0000-4,000,000$67.20M$0—-$67.20M
Mobileye Global Inc.CL A(MBLY)1,194,8390-1,194,839$38.41M$0—-$38.41M
Page 1 of 1
GENERAL ATLANTIC, L.P. — 13F Holdings — Q2 2024 | TickerTrail